Comerica Bank Mirum Pharmaceuticals, Inc. Transaction History
Comerica Bank
- $24.4 Billion
- Q4 2024
A detailed history of Comerica Bank transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 617 shares of MIRM stock, worth $29,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
617
Previous 588
4.93%
Holding current value
$29,079
Previous $22,000
13.64%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$310 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$216 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$153 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$132 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$123 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.73B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...